Quantitative phosphoproteomic analysis of IL‐33‐mediated signaling

Interleukin‐33 (IL‐33) is a novel member of the IL‐1 family of cytokines that plays diverse roles in the regulation of immune responses. IL‐33 exerts its effects through a heterodimeric receptor complex resulting in the production and release of proinflammatory cytokines. A detailed understanding of the signaling pathways activated by IL‐33 is still unclear. To gain insights into the IL‐33‐mediated signaling mechanisms, we carried out a SILAC‐based global quantitative phosphoproteomic analysis that resulted in the identification of 7191 phosphorylation sites derived from 2746 proteins. We observed alterations in the level of phosphorylation in 1050 sites corresponding to 672 proteins upon IL‐33 stimulation. We report, for the first time, phosphorylation of multiple protein kinases, including mitogen‐activated protein kinase activated protein kinase 2 (Mapkapk2), receptor (TNFRSF) interacting serine‐threonine kinase 1 (Ripk1), and NAD kinase (Nadk) that are induced by IL‐33. In addition, we observed IL‐33‐induced phosphorylation of several protein phosphatases including protein tyrosine phosphatase, nonreceptor‐type 12 (Ptpn12), and inositol polyphosphate‐5‐phosphatase D (Inpp5d), which have not been reported previously. Network analysis revealed an enrichment of actin binding and cytoskeleton reorganization that could be important in macrophage activation induced by IL‐33. Our study is the first quantitative analysis of IL‐33‐regulated phosphoproteome. Our findings significantly expand the understanding of IL‐33‐mediated signaling events and have the potential to provide novel therapeutic targets pertaining to immune‐related diseases such as asthma where dysregulation of IL‐33 is observed. All MS data have been deposited in the ProteomeXchange with identifier PXD000984 (http://proteomecentral.proteomexchange.org/dataset/PXD000984).

[1]  Liang Dong,et al.  IL-33 promotes airway remodeling and is a marker of asthma disease severity , 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.

[2]  D. Weiner,et al.  Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity. , 2014, Cancer research.

[3]  Andrew R. Jones,et al.  ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.

[4]  Akhilesh Pandey,et al.  Phosphoproteome of Cryptococcus neoformans. , 2014, Journal of proteomics.

[5]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[6]  C. McSharry,et al.  Interleukin‐33 exacerbates acute colitis via interleukin‐4 in mice , 2013, Immunology.

[7]  D. Voehringer,et al.  Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. , 2013, Immunity.

[8]  K. Nakanishi,et al.  Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice , 2013, Proceedings of the National Academy of Sciences.

[9]  Anushya Muruganujan,et al.  Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.

[10]  T. Wynn,et al.  Macrophages as IL-25/IL-33-Responsive Cells Play an Important Role in the Induction of Type 2 Immunity , 2013, PloS one.

[11]  M. Sakaguchi,et al.  DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells. , 2013, Oncology reports.

[12]  T. Reunala,et al.  IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. , 2012, The Journal of investigative dermatology.

[13]  Xinchun Chen,et al.  IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8+ T cells , 2011, European journal of immunology.

[14]  Daniel Schwartz,et al.  Biological sequence motif discovery using motif-x. , 2011, Current protocols in bioinformatics.

[15]  B. Ryffel,et al.  IL‐33‐activated dendritic cells are critical for allergic airway inflammation , 2011, European journal of immunology.

[16]  M. Kelliher,et al.  A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF-κB and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA Damage , 2011, Molecular and Cellular Biology.

[17]  Soohyun Kim,et al.  Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant* , 2011, The Journal of Biological Chemistry.

[18]  F. Liew,et al.  IL-33 Activates B1 Cells and Exacerbates Contact Sensitivity , 2011, The Journal of Immunology.

[19]  S. Tominaga,et al.  JAK2 is an important signal transducer in IL-33-induced NF-κB activation. , 2011, Cellular signalling.

[20]  A. Matsuda,et al.  IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells , 2010, The Journal of Immunology.

[21]  G. Ju,et al.  KU812 cells provide a novel in vitro model of the human IL-33/ST2L axis: functional responses and identification of signaling pathways. , 2010, Experimental cell research.

[22]  David Díaz-Jiménez,et al.  Characterization of the novel ST2/IL‐33 system in patients with inflammatory bowel disease , 2010, Inflammatory bowel diseases.

[23]  E. Tham,et al.  Modulation of interleukin signalling and gene expression in cardiac myocytes by endothelin-1. , 2010, The international journal of biochemistry & cell biology.

[24]  H. Gascan,et al.  Interleukin-33 overexpression is associated with liver fibrosis in mice and humans , 2009, Journal of cellular and molecular medicine.

[25]  C. Wong,et al.  Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation , 2010, Cellular and Molecular Immunology.

[26]  T. Mcclanahan,et al.  IL-33 Induces IL-13–Dependent Cutaneous Fibrosis , 2009, The Journal of Immunology.

[27]  Richard T. Lee,et al.  Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling , 2009, Circulation. Heart failure.

[28]  Qutayba Hamid,et al.  Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.

[29]  Bo-Jeong Pyun,et al.  Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. , 2009, Blood.

[30]  J. Girard,et al.  The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 , 2009, Proceedings of the National Academy of Sciences.

[31]  J. Girard,et al.  The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? , 2008, PloS one.

[32]  M. Hayakawa,et al.  TRAF6 is a critical signal transducer in IL-33 signaling pathway. , 2008, Cellular signalling.

[33]  Akhilesh Pandey,et al.  Quantitative proteomics using stable isotope labeling with amino acids in cell culture , 2008, Nature Protocols.

[34]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[35]  Dirk E. Smith,et al.  Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1 , 2007, The Journal of Immunology.

[36]  Delphine A. Lacorre,et al.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.

[37]  Ki-Young Lee,et al.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. , 2005, Genes & development.

[38]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[39]  P. Roepstorff,et al.  Highly Selective Enrichment of Phosphorylated Peptides from Peptide Mixtures Using Titanium Dioxide Microcolumns* , 2005, Molecular & Cellular Proteomics.

[40]  J. Rush,et al.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells , 2005, Nature Biotechnology.

[41]  E. S. Baekkevold,et al.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. , 2003, The American journal of pathology.

[42]  M. Mann,et al.  Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. , 2003, Analytical chemistry.

[43]  Philip Smith,et al.  Characterization of Signaling Pathways Activated by the Interleukin 1 (IL-1) Receptor Homologue T1/ST2 , 2002, The Journal of Biological Chemistry.

[44]  T. Stossel,et al.  Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1 , 2002, Nature Cell Biology.

[45]  Marc W. Kirschner,et al.  A PtdInsP3- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity , 2002, Nature Cell Biology.

[46]  K. Kosik,et al.  Evidence for the Involvement of Tiam1 in Axon Formation , 2001, The Journal of Neuroscience.

[47]  C. Meisel,et al.  Regulation and Function of T1/ST2 Expression on CD4+ T Cells: Induction of Type 2 Cytokine Production by T1/ST2 Cross-Linking1 , 2001, The Journal of Immunology.

[48]  守屋 綾子,et al.  Neurabin-II/Spinophilin AN ACTIN FILAMENT-BINDING PROTEIN WITH ONE PDZ DOMAIN LOCALIZED AT CADHERIN-BASED CELL-CELL ADHESION SITES , 2001 .

[49]  D. Hartshorne,et al.  Inhibitory Phosphorylation Site for Rho-associated Kinase on Smooth Muscle Myosin Phosphatase* , 1999, The Journal of Biological Chemistry.

[50]  A. Reske-Kunz,et al.  Mouse langerhans cells differentially express an activated T cell-attracting CC chemokine. , 1999, The Journal of investigative dermatology.

[51]  J. Schelling,et al.  The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. , 1999, The Journal of clinical investigation.

[52]  Y. Hata,et al.  Neurabin-II/Spinophilin , 1998, The Journal of Biological Chemistry.

[53]  John G. Collard,et al.  Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. , 1997, Science.

[54]  Philip R. Cohen,et al.  Identification of novel phosphorylation sites required for activation of MAPKAP kinase‐2. , 1995, The EMBO journal.

[55]  B. Dérijard,et al.  Cdc42 and PAK-mediated Signaling Leads to Jun Kinase and p38 Mitogen-activated Protein Kinase Activation (*) , 1995, The Journal of Biological Chemistry.

[56]  M. Gaestel,et al.  Constitutive Activation of Mitogen-activated Protein Kinase-activated Protein Kinase 2 by Mutation of Phosphorylation Sites and an A-helix Motif (*) , 1995, The Journal of Biological Chemistry.

[57]  C. Nobes,et al.  Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia , 1995, Cell.

[58]  N. Tonks,et al.  PTP‐PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. , 1994, The EMBO journal.

[59]  John G. Collard,et al.  Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins , 1994, Cell.

[60]  J. Saklatvala,et al.  Interleukin-1 signal transduction. Increased GTP binding and hydrolysis in membranes of a murine thymoma line (EL4). , 1990, The Journal of biological chemistry.